Answer to antibiotic-resistant infections could already be on the market

The rise of antibiotic resistant bacterial pathogens is an increasingly global threat to public health. In the United States alone, antibiotic resistant bacterial pathogens kill thousands every year. But non-antibiotic therapeutic drugs already approved for other purposes in people could be effective in fighting the antibiotic-resistant pathogens, according to a new study.